CompoSecure (CMPO) Financials

$11.30 +0.25 (+2.26%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$11.30 +0.00 (+0.04%)

As of 05/2/2025 04:05 PM Eastern

Annual Income Statements for CompoSecure

This table shows CompoSecure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	81	78	3.15	19	19	-54
Consolidated Net Income / (Loss)	81	78	83	132	113	-83
Net Income / (Loss) Continuing Operations	81	78	83	132	113	-83
Total Pre-Tax Income	81	78	83	136	117	-81
Total Operating Income	87	84	81	115	119	108
Total Gross Profit	128	133	145	220	209	219
Total Revenue	243	261	268	378	391	421
Operating Revenue	243	261	268	378	391	421
Total Cost of Revenue	115	128	123	159	182	201
Operating Cost of Revenue	115	128	123	159	182	201
Total Operating Expenses	41	49	63	105	90	112
Selling, General & Admin Expense	41	49	63	105	90	112
Total Other Income / (Expense), net	-5.45	-6.14	1.13	21	-2.01	-189
Interest Expense	-	-	-	21	28	20
Interest & Investment Income	-4.75	-5.27	-10	1.25	4.98	4.65
Other Income / (Expense), net	-0.70	-0.88	11	41	21	-173
Income Tax Expense	0.00	0.00	-0.86	4.36	4.56	2.19
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	80	113	93	-29
Basic Earnings per Share	$0.00	$0.00	$0.21	$1.21	$1.03	($1.22)
Weighted Average Basic Shares Outstanding	0.00	0.00	14.93M	15.37M	18.66M	44.01M
Diluted Earnings per Share	$0.00	$0.00	$0.12	$1.13	$0.96	($1.22)
Weighted Average Diluted Shares Outstanding	0.00	0.00	94.57M	32.56M	35.31M	44.01M
Weighted Average Basic & Diluted Shares Outstanding	-	-	76.07M	77.88M	80.53M	102.31M

This table shows CompoSecure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	2.82	3.97	2.33	5.74	7.48	3.70	4.03	11	-42	-27
Consolidated Net Income / (Loss)	22	22	11	33	38	31	17	34	-85	-48
Net Income / (Loss) Continuing Operations	22	22	11	33	38	31	17	34	-85	-48
Total Pre-Tax Income	22	23	9.47	34	39	35	16	34	-85	-46
Total Operating Income	26	25	29	30	29	31	31	32	29	16
Total Gross Profit	62	50	53	54	49	53	55	56	55	53
Total Revenue	103	94	95	99	97	100	104	109	107	101
Operating Revenue	103	94	95	99	97	100	104	109	107	101
Total Cost of Revenue	42	44	42	45	48	47	49	52	52	48
Operating Cost of Revenue	42	44	42	45	48	47	49	52	52	48
Total Operating Expenses	36	25	24	24	20	22	24	24	26	37
Selling, General & Admin Expense	36	25	24	24	20	22	24	24	26	37
Total Other Income / (Expense), net	-3.36	-1.69	-20	3.33	10	4.40	-15	2.06	-114	-62
Interest & Investment Income	-5.30	16	-5.93	-5.44	-5.70	22	-5.42	-5.32	-5.14	21
Other Income / (Expense), net	1.94	3.90	-14	8.77	16	9.88	-9.48	7.38	-109	-62
Income Tax Expense	0.39	0.62	-1.26	0.97	0.95	3.90	-0.84	0.26	0.63	2.14
Net Income / (Loss) Attributable to Noncontrolling Interest	19	18	8.41	27	31	27	13	22	-43	-22
Basic Earnings per Share	$0.18	$0.24	$0.13	$0.31	$0.39	$0.20	$0.20	$0.44	($1.10)	($0.76)
Weighted Average Basic Shares Outstanding	15.43M	15.37M	17.63M	18.54M	19.07M	18.66M	20.57M	25.44M	38.21M	44.01M
Diluted Earnings per Share	$0.18	$0.20	$0.11	$0.29	$0.34	$0.22	$0.17	$0.32	($1.10)	($0.61)
Weighted Average Diluted Shares Outstanding	19.66M	32.56M	94.74M	35.53M	35.76M	35.31M	96.24M	96.64M	38.21M	44.01M
Weighted Average Basic & Diluted Shares Outstanding	76.35M	77.88M	78.39M	79.00M	79.32M	80.53M	80.59M	81.91M	88.13M	102.31M

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	14	-13	8.52	-8.30	28	36
Net Cash From Operating Activities	81	87	78	93	104	130
Net Cash From Continuing Operating Activities	81	87	78	93	104	130
Net Income / (Loss) Continuing Operations	81	78	83	132	113	-83
Consolidated Net Income / (Loss)	81	78	83	132	113	-83
Depreciation Expense	8.61	9.92	10	8.58	8.39	9.17
Amortization Expense	0.67	0.84	1.65	2.35	1.55	1.16
Non-Cash Adjustments To Reconcile Net Income	1.21	3.01	3.23	-29	-5.77	193
Changes in Operating Assets and Liabilities, net	-11	-4.52	-21	-21	-12	9.48
Net Cash From Investing Activities	-9.64	-7.50	-4.75	-9.05	-11	-9.95
Net Cash From Continuing Investing Activities	-9.64	-7.50	-4.75	-9.05	-11	-9.95
Purchase of Property, Plant & Equipment	-9.64	-7.50	-4.75	-9.05	-11	-8.45
Other Investing Activities, net	-	-	-	0.00	0.00	-1.50
Net Cash From Financing Activities	-58	-93	-65	-92	-66	-83
Net Cash From Continuing Financing Activities	-58	-93	-65	-92	-66	-83
Repayment of Debt	-30	-14	-247	-32	-23	-15
Payment of Dividends	-104	-217	-241	-36	-38	-59
Issuance of Common Equity	0.00	0.00	61	0.08	1.20	5.00
Other Financing Activities, net	0.00	0.00	-15	-24	-5.56	-14
Cash Interest Paid	4.89	5.32	10	21	27	21
Cash Income Taxes Paid	-	-	0.00	0.86	2.76	4.82

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	2.04	-1.79	8.92	0.05	1.20	17	14	-20	17	25
Net Cash From Operating Activities	31	11	25	28	25	26	34	32	28	35
Net Cash From Continuing Operating Activities	31	11	25	28	25	26	34	32	28	35
Net Income / (Loss) Continuing Operations	22	22	11	33	38	31	17	34	-85	-48
Consolidated Net Income / (Loss)	22	22	11	33	38	31	17	34	-85	-48
Depreciation Expense	2.01	2.00	2.04	2.13	2.08	2.14	2.22	2.38	2.33	2.24
Amortization Expense	0.55	0.55	0.56	0.14	0.56	0.28	0.35	0.32	0.29	0.20
Non-Cash Adjustments To Reconcile Net Income	5.13	-21	15	-2.81	-1.03	-17	12	-1.01	80	102
Changes in Operating Assets and Liabilities, net	0.99	6.51	-3.93	-4.08	-15	10	2.02	-3.04	31	-20
Net Cash From Investing Activities	-3.72	-1.83	-3.67	-2.03	-0.97	-4.28	-1.61	-1.91	-1.98	-4.43
Net Cash From Continuing Investing Activities	-3.72	-1.83	-3.67	-2.03	-0.97	-4.28	-1.61	-1.91	-1.98	-4.43
Purchase of Property, Plant & Equipment	-3.72	-1.83	-3.67	-2.03	-0.97	-4.28	-1.61	-1.91	-1.98	-2.93
Net Cash From Financing Activities	-25	-11	-12	-26	-23	-4.76	-18	-50	-8.87	-6.20
Net Cash From Continuing Financing Activities	-25	-11	-12	-26	-23	-4.76	-18	-50	-8.87	-6.20
Repayment of Debt	-5.00	-10	-0.33	-4.69	-13	-4.69	-4.69	-4.69	-2.85	-2.70
Issuance of Common Equity	0.00	0.08	0.15	0.24	0.64	0.17	0.11	0.11	2.67	2.10
Other Financing Activities, net	-	-0.11	-2.41	-2.27	-0.64	-0.24	-3.48	-21	16	-5.60
Cash Interest Paid	5.30	6.44	4.57	9.06	4.67	8.95	4.18	8.72	4.10	3.62

This table presents CompoSecure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	81	131	163	201	474
Total Current Assets	53	78	97	139	174
Cash & Equivalents	13	22	14	41	77
Accounts Receivable	8.79	28	37	40	47
Inventories, net	30	26	42	53	45
Prepaid Expenses	1.08	2.60	3.82	5.13	4.16
Plant, Property, & Equipment, net	28	22	23	25	23
Total Noncurrent Assets	0.01	31	43	36	277
Noncurrent Deferred & Refundable Income Taxes	0.00	26	26	24	265
Other Noncurrent Operating Assets	0.01	5.26	18	13	12
Total Liabilities & Shareholders' Equity	81	131	163	201	474
Total Liabilities	274	539	455	407	617
Total Current Liabilities	42	61	47	41	76
Short-Term Debt	24	13	14	10	11
Accounts Payable	2.42	7.06	7.13	5.19	12
Accrued Expenses	12	10	10	12	15
Current Deferred & Payable Income Tax Liabilities	-	-	2.37	1.43	5.17
Other Current Liabilities	3.64	31	13	12	34
Total Noncurrent Liabilities	232	478	408	366	541
Long-Term Debt	232	375	344	326	184
Capital Lease Obligations	-	-	-	6.22	3.89
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	24	24	249
Other Noncurrent Operating Liabilities	0.41	103	39	9.51	104
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.00	608	600	597	0.00
Total Equity & Noncontrolling Interests	-193	-1,016	-892	-802	-143
Total Preferred & Common Equity	-193	-1,016	-892	-802	-143
Preferred Stock	-	0.00	0.00	0.00	0.00
Total Common Equity	-193	-1,016	-892	-802	-143
Common Stock	6.15	12	24	39	361
Retained Earnings	-199	-1,028	-925	-847	-507
Accumulated Other Comprehensive Income / (Loss)	-	0.00	8.28	4.99	2.54

This table presents CompoSecure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	170	186	181	195	214	213	435
Total Current Assets	103	117	112	128	151	136	157
Cash & Equivalents	15	23	23	24	55	35	53
Accounts Receivable	46	39	37	49	35	40	44
Inventories, net	39	51	49	52	55	58	55
Prepaid Expenses	2.82	4.20	4.10	3.91	5.25	3.93	5.25
Plant, Property, & Equipment, net	23	24	24	23	25	24	23
Total Noncurrent Assets	44	44	45	44	38	53	256
Noncurrent Deferred & Refundable Income Taxes	25	28	28	28	26	41	245
Other Noncurrent Operating Assets	19	16	17	16	13	12	10
Total Liabilities & Shareholders' Equity	170	186	181	195	214	213	435
Total Liabilities	495	477	453	434	411	422	720
Total Current Liabilities	67	59	51	53	42	49	65
Short-Term Debt	9.69	19	19	10	12	13	10
Accounts Payable	13	15	6.64	14	4.75	9.43	9.69
Accrued Expenses	20	12	11	14	13	12	13
Current Deferred & Payable Income Tax Liabilities	-	2.37	1.67	1.67	1.43	1.43	0.12
Other Current Liabilities	24	10	13	13	11	13	31
Total Noncurrent Liabilities	428	418	402	381	369	373	656
Long-Term Debt	358	339	335	331	320	314	316
Noncurrent Deferred & Payable Income Tax Liabilities	-	25	24	24	24	43	234
Other Noncurrent Operating Liabilities	70	53	43	27	24	16	105
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	603	597	597	597	597	516	0.00
Total Equity & Noncontrolling Interests	-928	-888	-868	-835	-794	-726	-285
Total Preferred & Common Equity	-928	-888	-868	-835	-794	-726	-285
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-928	-888	-868	-835	-794	-726	-285
Common Stock	21	26	30	35	41	36	180
Retained Earnings	-958	-920	-907	-878	-840	-767	-468
Accumulated Other Comprehensive Income / (Loss)	9.00	6.63	7.91	7.65	5.44	4.85	2.57

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	7.11%	2.83%	41.25%	3.21%	7.67%
EBITDA Growth	0.00%	-1.74%	11.76%	59.45%	-10.56%	-136.76%
EBIT Growth	0.00%	-3.65%	11.69%	68.45%	-10.67%	-146.77%
NOPAT Growth	0.00%	-3.41%	-2.01%	35.18%	2.91%	-34.18%
Net Income Growth	0.00%	-4.49%	7.20%	58.03%	-14.64%	-173.91%
EPS Growth	0.00%	0.00%	0.00%	841.67%	-15.04%	-227.08%
Operating Cash Flow Growth	0.00%	7.24%	-10.66%	19.29%	12.43%	24.20%
Free Cash Flow Firm Growth	0.00%	0.00%	411.78%	-90.36%	323.34%	170.63%
Invested Capital Growth	0.00%	0.00%	-184.28%	224.46%	82.80%	-122.34%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	5.14%	1.59%	0.23%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	4.00%	8.35%	-271.87%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	4.68%	9.10%	-401.32%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	14.56%	2.16%	102.78%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	1.80%	8.35%	-2,100.05%
EPS Q/Q Growth	0.00%	0.00%	0.00%	7.62%	2.13%	-212.82%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	-16.93%	17.60%	7.45%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	16.56%	107.35%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	92.57%	22.36%	-88.97%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	52.56%	50.90%	54.06%	58.03%	53.52%	52.13%
EBITDA Margin	39.25%	36.01%	39.14%	44.18%	38.29%	-13.07%
Operating Margin	35.73%	32.22%	30.39%	30.36%	30.49%	25.59%
EBIT Margin	35.44%	31.88%	34.63%	41.30%	35.74%	-15.53%
Profit (Net Income) Margin	33.49%	29.86%	31.13%	34.83%	28.80%	-19.77%
Tax Burden Percent	100.00%	100.00%	101.04%	96.80%	96.11%	102.70%
Interest Burden Percent	94.49%	93.66%	88.97%	87.12%	83.85%	124.01%
Effective Tax Rate	0.00%	0.00%	-1.04%	3.20%	3.89%	0.00%
Return on Invested Capital (ROIC)	0.00%	336.43%	2,097.13%	2,161.43%	154.60%	202.71%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	331.36%	2,097.50%	2,167.23%	154.00%	127.87%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-417.25%	-2,124.92%	-2,199.11%	-199.81%	-155.09%
Return on Equity (ROE)	0.00%	-80.82%	-27.80%	-37.68%	-45.21%	47.63%
Cash Return on Invested Capital (CROIC)	0.00%	136.43%	0.00%	32.08%	96.04%	0.00%
Operating Return on Assets (OROA)	0.00%	102.12%	87.25%	106.22%	76.72%	-19.35%
Return on Assets (ROA)	0.00%	95.65%	78.43%	89.58%	61.83%	-24.64%
Return on Common Equity (ROCE)	0.00%	-80.82%	-55.97%	-102.77%	-153.91%	128.99%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-40.41%	-8.21%	-14.77%	-14.02%	57.97%
Net Operating Profit after Tax (NOPAT)	87	84	82	111	114	75
NOPAT Margin	35.73%	32.22%	30.70%	29.39%	29.30%	17.91%
Net Nonoperating Expense Percent (NNEP)	0.00%	5.07%	-0.38%	-5.80%	0.60%	74.84%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-20.82%	-24.90%	134.33%
Cost of Revenue to Revenue	47.44%	49.10%	45.94%	41.97%	46.48%	47.87%
SG&A Expenses to Revenue	16.83%	18.68%	23.67%	27.68%	23.04%	26.54%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	16.83%	18.68%	23.67%	27.68%	23.04%	26.54%
Earnings before Interest and Taxes (EBIT)	86	83	93	156	140	-65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	96	94	105	167	150	-55
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.90	1.07	0.85	0.75	0.83	2.55
Price to Earnings (P/E)	2.70	3.59	71.94	15.25	16.90	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	2.46%
Earnings Yield	37.03%	27.85%	1.39%	6.56%	5.92%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	10.46	0.00	23.48	12.78	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	2.00	4.48	3.25	3.13	2.84
Enterprise Value to EBITDA (EV/EBITDA)	0.00	5.56	11.45	7.35	8.18	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	6.28	12.94	7.86	8.76	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	6.22	14.60	11.05	10.69	15.88
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	5.99	15.44	13.25	11.73	9.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	15.33	6.89	73.19	17.20	6.22
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	-1.33	-0.95	-1.23	-1.67	-1.39
Long-Term Debt to Equity	0.00	-1.20	-0.92	-1.18	-1.62	-1.31
Financial Leverage	0.00	-1.26	-1.01	-1.01	-1.30	-1.21
Leverage Ratio	0.00	-0.42	-0.35	-0.42	-0.73	-1.93
Compound Leverage Factor	0.00	-0.40	-0.32	-0.37	-0.61	-2.40
Debt to Total Capital	0.00%	404.03%	-1,925.99%	542.43%	250.28%	355.78%
Short-Term Debt to Total Capital	0.00%	37.89%	-62.12%	21.78%	7.53%	20.06%
Long-Term Debt to Total Capital	0.00%	366.14%	-1,863.87%	520.66%	242.75%	335.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	-3,023.26%	909.47%	435.71%	0.00%
Common Equity to Total Capital	0.00%	-304.03%	5,049.26%	-1,351.91%	-585.99%	-255.78%
Debt to EBITDA	0.00	2.73	3.70	2.14	2.29	-3.63
Net Debt to EBITDA	0.00	2.58	3.49	2.06	2.02	-2.22
Long-Term Debt to EBITDA	0.00	2.47	3.58	2.05	2.22	-3.43
Debt to NOPAT	0.00	3.05	4.71	3.22	2.99	2.65
Net Debt to NOPAT	0.00	2.89	4.44	3.10	2.63	1.62
Long-Term Debt to NOPAT	0.00	2.76	4.56	3.09	2.90	2.50
Altman Z-Score	0.00	3.94	-6.17	-1.71	-0.60	0.23
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	-101.35%	-172.74%	-240.44%	-170.83%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.29	1.29	2.05	3.40	2.28
Quick Ratio	0.00	0.53	0.82	1.08	1.99	1.64
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	34	174	17	71	192
Operating Cash Flow to CapEx	842.00%	1,160.67%	1,638.85%	1,024.89%	953.14%	1,534.08%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.79	2.58	9.47
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	4.34	3.79	6.37
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	3.92	3.39	5.96
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	3.20	2.52	2.57	2.15	1.25
Accounts Receivable Turnover	0.00	29.64	14.60	11.61	10.05	9.57
Inventory Turnover	0.00	4.24	4.40	4.66	3.83	4.14
Fixed Asset Turnover	0.00	9.35	10.71	16.88	16.32	17.29
Accounts Payable Turnover	0.00	52.85	25.97	22.39	29.47	24.06
Days Sales Outstanding (DSO)	0.00	12.31	25.01	31.44	36.33	38.16
Days Inventory Outstanding (DIO)	0.00	86.14	83.03	78.34	95.41	88.26
Days Payable Outstanding (DPO)	0.00	6.91	14.05	16.30	12.38	15.17
Cash Conversion Cycle (CCC)	0.00	91.55	93.98	93.48	119.36	111.25
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	50	-42	52	96	-21
Invested Capital Turnover	0.00	10.44	68.30	73.55	5.28	11.32
Increase / (Decrease) in Invested Capital	0.00	50	-92	94	43	-117
Enterprise Value (EV)	0.00	522	1,201	1,229	1,223	1,196
Market Capitalization	220	279	227	285	325	1,074
Book Value per Share	$0.00	($6.65)	($35.10)	($11.69)	($10.12)	($1.63)
Tangible Book Value per Share	$0.00	($6.65)	($35.10)	($11.69)	($10.12)	($1.63)
Total Capital	0.00	63	-20	66	137	56
Total Debt	0.00	256	388	358	343	200
Total Long-Term Debt	0.00	232	375	344	332	188
Net Debt	0.00	242	366	344	301	122
Capital Expenditures (CapEx)	9.64	7.50	4.75	9.05	11	8.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	22	8.31	50	68	31
Debt-free Net Working Capital (DFNWC)	0.00	36	30	64	109	109
Net Working Capital (NWC)	0.00	12	18	50	98	98
Net Nonoperating Expense (NNE)	5.45	6.14	-1.14	-21	1.93	158
Net Nonoperating Obligations (NNO)	0.00	242	366	344	301	122
Total Depreciation and Amortization (D&A)	9.28	11	12	11	9.93	10
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	8.62%	3.10%	13.34%	17.28%	7.46%
Debt-free Net Working Capital to Revenue	0.00%	13.77%	11.29%	16.94%	27.83%	25.88%
Net Working Capital to Revenue	0.00%	4.56%	6.63%	13.15%	25.19%	23.20%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.91	$1.21	$1.03	($1.22)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	14.93M	15.37M	18.66M	44.01M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.14	$1.13	$0.96	($1.22)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	94.93M	32.56M	35.31M	44.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	76.07M	77.88M	80.53M	102.31M
Normalized Net Operating Profit after Tax (NOPAT)	61	59	57	111	114	75
Normalized NOPAT Margin	25.01%	22.55%	21.27%	29.39%	29.30%	17.91%
Pre Tax Income Margin	33.49%	29.86%	30.81%	35.98%	29.97%	-19.25%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	7.31	5.07	-3.21
NOPAT to Interest Expense	0.00	0.00	0.00	5.20	4.16	3.71
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	6.89	4.68	-3.63
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	4.78	3.76	3.29
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	127.41%	278.44%	288.48%	27.53%	34.09%	-71.38%
Augmented Payout Ratio	127.41%	278.44%	288.48%	27.53%	34.09%	-71.38%

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	56.09%	24.55%	13.22%	1.37%	-6.21%	6.52%	9.12%	10.19%	10.58%	0.96%
EBITDA Growth	24.42%	25.89%	-48.20%	-41.72%	57.04%	36.82%	34.55%	1.16%	-262.55%	-203.03%
EBIT Growth	30.17%	32.14%	-51.54%	-42.62%	62.02%	40.51%	40.60%	0.13%	-278.01%	-215.25%
NOPAT Growth	16.64%	151.59%	13.41%	-10.41%	11.55%	12.15%	-1.77%	7.04%	-27.53%	-59.73%
Net Income Growth	17.12%	11.67%	-60.10%	-46.07%	73.79%	38.78%	59.01%	2.71%	-324.64%	-255.87%
EPS Growth	0.00%	66.67%	-52.17%	-44.23%	88.89%	10.00%	54.55%	10.34%	-423.53%	-377.27%
Operating Cash Flow Growth	46.69%	-63.60%	109.06%	-28.87%	-18.55%	144.25%	35.56%	14.83%	13.01%	33.99%
Free Cash Flow Firm Growth	0.00%	0.00%	-103.47%	-98.03%	-112.26%	76.89%	71.13%	100.43%	579.24%	888.57%
Invested Capital Growth	-85.62%	224.46%	1,406.57%	77.10%	187.70%	82.80%	78.90%	40.73%	-114.46%	-122.34%
Revenue Q/Q Growth	6.28%	-9.21%	1.63%	3.37%	-1.67%	3.11%	4.11%	4.38%	-1.32%	-5.86%
EBITDA Q/Q Growth	-57.56%	3.85%	-42.49%	129.94%	14.35%	-9.52%	-43.44%	72.88%	-283.74%	42.65%
EBIT Q/Q Growth	-59.54%	4.24%	-46.44%	153.99%	14.24%	-9.60%	-46.40%	80.88%	-303.11%	41.47%
NOPAT Q/Q Growth	-23.43%	-4.01%	37.85%	-11.57%	-4.66%	-3.50%	20.73%	-3.63%	-35.46%	-46.37%
Net Income Q/Q Growth	-63.91%	2.11%	-51.97%	204.65%	16.32%	-18.46%	-44.97%	96.78%	-354.41%	43.42%
EPS Q/Q Growth	-65.38%	11.11%	-45.00%	163.64%	17.24%	-35.29%	-22.73%	88.24%	-443.75%	44.55%
Operating Cash Flow Q/Q Growth	-22.57%	-64.60%	130.06%	12.80%	-11.34%	6.17%	27.69%	-4.45%	-12.75%	25.88%
Free Cash Flow Firm Q/Q Growth	-0.70%	-137.56%	88.30%	145.23%	-716.79%	29.21%	76.30%	414.04%	1,374.81%	16.48%
Invested Capital Q/Q Growth	-18.61%	92.57%	-15.00%	32.94%	32.21%	22.36%	-11.03%	4.58%	-113.59%	-88.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	59.78%	53.60%	55.98%	54.74%	50.47%	52.95%	53.08%	51.65%	51.72%	52.09%
EBITDA Margin	29.18%	33.37%	18.89%	42.01%	48.86%	42.87%	23.29%	38.57%	-71.82%	-43.75%
Operating Margin	24.82%	26.50%	30.86%	30.80%	29.73%	30.56%	29.94%	29.28%	27.15%	15.47%
EBIT Margin	26.70%	30.66%	16.16%	39.71%	46.13%	40.45%	20.82%	36.08%	-74.26%	-46.17%
Profit (Net Income) Margin	21.19%	23.84%	11.26%	33.20%	39.27%	31.06%	16.41%	30.95%	-79.78%	-47.95%
Tax Burden Percent	98.24%	97.29%	113.33%	97.12%	97.57%	88.83%	105.15%	99.24%	100.74%	104.62%
Interest Burden Percent	80.79%	79.90%	61.51%	86.09%	87.26%	86.43%	74.98%	86.43%	106.64%	99.26%
Effective Tax Rate	1.76%	2.71%	-13.33%	2.88%	2.43%	11.17%	-5.15%	0.76%	0.00%	0.00%
Return on Invested Capital (ROIC)	81.19%	1,896.28%	574.15%	252.68%	211.60%	143.23%	202.54%	167.06%	238.43%	122.53%
ROIC Less NNEP Spread (ROIC-NNEP)	79.32%	1,895.76%	567.84%	253.60%	214.58%	144.44%	197.42%	167.71%	202.59%	94.54%
Return on Net Nonoperating Assets (RNNOA)	-205.63%	-1,923.65%	-608.19%	-292.28%	-254.70%	-187.41%	-247.58%	-217.37%	-228.47%	-114.67%
Return on Equity (ROE)	-124.44%	-27.37%	-34.04%	-39.60%	-43.10%	-44.17%	-45.05%	-50.31%	9.96%	7.87%
Cash Return on Invested Capital (CROIC)	0.00%	32.08%	296.27%	180.61%	115.74%	96.04%	130.26%	131.93%	0.00%	0.00%
Operating Return on Assets (OROA)	47.32%	78.86%	38.24%	93.25%	97.24%	86.81%	41.64%	74.89%	-98.85%	-57.54%
Return on Assets (ROA)	37.55%	61.31%	26.66%	77.97%	82.78%	66.66%	32.83%	64.24%	-106.19%	-59.75%
Return on Common Equity (ROCE)	-893.37%	-74.65%	-95.46%	-118.11%	-134.81%	-150.38%	-155.06%	-166.74%	21.29%	21.31%
Return on Equity Simple (ROE_SIMPLE)	-13.96%	0.00%	-13.03%	-10.10%	-12.43%	0.00%	-14.97%	-16.50%	1.33%	0.00%
Net Operating Profit after Tax (NOPAT)	25	24	33	29	28	27	33	32	20	11
NOPAT Margin	24.38%	25.78%	34.97%	29.92%	29.00%	27.15%	31.48%	29.06%	19.01%	10.83%
Net Nonoperating Expense Percent (NNEP)	1.87%	0.51%	6.32%	-0.92%	-2.97%	-1.21%	5.11%	-0.66%	35.83%	27.99%
Return On Investment Capital (ROIC_SIMPLE)	-	-4.53%	-	-	-	-5.90%	-	-	-	19.47%
Cost of Revenue to Revenue	40.22%	46.40%	44.02%	45.26%	49.53%	47.05%	46.92%	48.35%	48.28%	47.91%
SG&A Expenses to Revenue	34.96%	27.11%	25.12%	23.94%	20.74%	22.39%	23.15%	22.36%	24.56%	36.62%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	34.96%	27.11%	25.12%	23.94%	20.74%	22.39%	23.15%	22.36%	24.56%	36.62%
Earnings before Interest and Taxes (EBIT)	28	29	15	39	45	40	22	39	-80	-47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	30	31	18	41	47	43	24	42	-77	-44
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.01	0.75	1.40	1.31	1.27	0.83	1.39	1.34	2.74	2.55
Price to Earnings (P/E)	0.00	15.25	31.11	34.56	24.93	16.90	26.55	20.84	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.41%	2.14%	2.46%
Earnings Yield	0.00%	6.56%	3.21%	2.89%	4.01%	5.92%	3.77%	4.80%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	48.51	23.48	33.24	24.36	17.90	12.78	17.95	16.30	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	3.66	3.25	3.80	3.69	3.64	3.13	3.58	3.31	3.39	2.84
Enterprise Value to EBITDA (EV/EBITDA)	8.20	7.35	9.83	11.93	10.14	8.18	9.18	8.68	44.46	0.00
Enterprise Value to EBIT (EV/EBIT)	8.83	7.86	10.57	13.00	10.94	8.76	9.80	9.30	65.62	0.00
Enterprise Value to NOPAT (EV/NOPAT)	13.59	11.05	13.23	13.18	12.50	10.69	12.33	11.49	0.00	15.88
Enterprise Value to Operating Cash Flow (EV/OCF)	11.81	13.25	13.99	15.27	15.79	11.73	12.63	11.56	11.79	9.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	73.19	21.05	17.24	22.95	17.20	17.68	14.44	0.00	6.22
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-1.13	-1.23	-1.23	-1.30	-1.43	-1.67	-1.68	-1.57	-1.15	-1.39
Long-Term Debt to Equity	-1.10	-1.18	-1.17	-1.23	-1.38	-1.62	-1.62	-1.50	-1.11	-1.31
Financial Leverage	-2.59	-1.01	-1.07	-1.15	-1.19	-1.30	-1.25	-1.30	-1.13	-1.21
Leverage Ratio	-2.99	-0.42	-0.49	-0.55	-0.65	-0.73	-0.82	-0.82	-1.20	-1.93
Compound Leverage Factor	-2.42	-0.34	-0.30	-0.47	-0.56	-0.63	-0.61	-0.71	-1.28	-1.92
Debt to Total Capital	862.19%	542.43%	534.11%	432.49%	334.07%	250.28%	246.46%	276.24%	789.09%	355.78%
Short-Term Debt to Total Capital	22.73%	21.78%	27.96%	22.93%	10.13%	7.53%	8.81%	11.32%	24.18%	20.06%
Long-Term Debt to Total Capital	839.47%	520.66%	506.15%	409.56%	323.95%	242.75%	237.65%	264.92%	764.92%	335.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1,414.52%	909.47%	889.50%	729.53%	584.68%	435.71%	442.70%	435.29%	0.00%	0.00%
Common Equity to Total Capital	-2,176.71%	-1,351.91%	-1,323.61%	-1,062.02%	-818.75%	-585.99%	-589.16%	-611.54%	-689.09%	-255.78%
Debt to EBITDA	2.29	2.14	2.38	2.93	2.47	2.29	2.13	2.10	10.20	-3.63
Net Debt to EBITDA	2.19	2.06	2.23	2.74	2.30	2.02	1.78	1.87	8.56	-2.22
Long-Term Debt to EBITDA	2.23	2.05	2.26	2.77	2.39	2.22	2.06	2.01	9.89	-3.43
Debt to NOPAT	3.78	3.22	3.20	3.23	3.04	2.99	2.86	2.78	-0.12	2.65
Net Debt to NOPAT	3.63	3.10	3.00	3.03	2.83	2.63	2.39	2.48	-0.10	1.62
Long-Term Debt to NOPAT	3.69	3.09	3.04	3.06	2.95	2.90	2.76	2.66	-0.12	2.50
Altman Z-Score	-4.54	-4.30	-3.50	-3.05	-2.44	-2.22	-1.88	-1.24	0.07	0.36
Noncontrolling Interest Sharing Ratio	-617.92%	-172.74%	-180.44%	-198.25%	-212.79%	-240.44%	-244.24%	-231.40%	-113.88%	-170.83%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.54	2.05	1.98	2.21	2.43	3.40	3.56	2.79	2.43	2.28
Quick Ratio	0.91	1.08	1.04	1.16	1.37	1.99	2.13	1.53	1.49	1.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	187	-70	-8.22	3.72	-23	-16	-2.37	7.45	110	128
Operating Cash Flow to CapEx	822.44%	590.72%	679.13%	1,382.77%	2,561.52%	618.32%	2,092.44%	1,684.90%	1,418.15%	1,207.12%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	742.56	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	190.11	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	176.70	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.77	2.57	2.37	2.35	2.11	2.15	2.00	2.08	1.33	1.25
Accounts Receivable Turnover	0.00	11.61	10.02	9.57	8.15	10.05	10.75	10.75	9.09	9.57
Inventory Turnover	0.00	4.66	4.21	4.42	3.91	3.83	3.54	3.69	3.74	4.14
Fixed Asset Turnover	0.00	16.88	17.12	17.26	16.76	16.32	16.34	17.08	18.19	17.29
Accounts Payable Turnover	20.05	22.39	16.29	25.44	13.34	29.47	18.61	24.44	16.84	24.06
Days Sales Outstanding (DSO)	0.00	31.44	36.43	38.16	44.77	36.33	33.96	33.96	40.16	38.16
Days Inventory Outstanding (DIO)	0.00	78.34	86.60	82.56	93.39	95.41	103.15	98.93	97.70	88.26
Days Payable Outstanding (DPO)	18.20	16.30	22.41	14.35	27.36	12.38	19.61	14.94	21.68	15.17
Cash Conversion Cycle (CCC)	-18.20	93.48	100.62	106.37	110.80	119.36	117.49	117.95	116.18	111.25
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	27	52	45	59	78	96	80	83	-11	-21
Invested Capital Turnover	3.33	73.55	16.42	8.45	7.30	5.28	6.43	5.75	12.54	11.32
Increase / (Decrease) in Invested Capital	-162	94	42	26	51	43	35	24	-90	-117
Enterprise Value (EV)	1,319	1,229	1,480	1,441	1,400	1,223	1,429	1,357	1,422	1,196
Market Capitalization	364	285	547	513	487	325	556	548	1,148	1,074
Book Value per Share	($12.19)	($11.69)	($11.40)	($11.08)	($10.57)	($10.12)	($9.86)	($9.00)	($3.48)	($1.63)
Tangible Book Value per Share	($12.19)	($11.69)	($11.40)	($11.08)	($10.57)	($10.12)	($9.86)	($9.00)	($3.48)	($1.63)
Total Capital	43	66	67	82	102	137	135	119	41	56
Total Debt	367	358	358	354	341	343	332	328	326	200
Total Long-Term Debt	358	344	339	335	331	332	320	314	316	188
Net Debt	352	344	336	331	317	301	277	292	274	122
Capital Expenditures (CapEx)	3.72	1.83	3.67	2.03	0.97	4.28	1.61	1.91	1.98	2.93
Debt-free, Cash-free Net Working Capital (DFCFNWC)	30	50	54	57	62	68	65	66	50	31
Debt-free Net Working Capital (DFNWC)	46	64	77	80	86	109	120	101	102	109
Net Working Capital (NWC)	36	50	58	61	75	98	108	87	92	98
Net Nonoperating Expense (NNE)	3.30	1.82	23	-3.24	-9.95	-3.91	16	-2.05	106	59
Net Nonoperating Obligations (NNO)	352	344	336	331	317	301	277	292	274	122
Total Depreciation and Amortization (D&A)	2.56	2.55	2.60	2.27	2.64	2.42	2.57	2.70	2.62	2.44
Debt-free, Cash-free Net Working Capital to Revenue	8.47%	13.34%	13.94%	14.69%	16.10%	17.28%	16.30%	16.01%	11.81%	7.46%
Debt-free Net Working Capital to Revenue	12.76%	16.94%	19.73%	20.47%	22.29%	27.83%	30.11%	24.66%	24.36%	25.88%
Net Working Capital to Revenue	10.07%	13.15%	14.92%	15.68%	19.60%	25.19%	27.13%	21.37%	21.98%	23.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.18	$0.24	$0.13	$0.31	$0.39	$0.20	$0.20	$0.44	($1.10)	($0.76)
Adjusted Weighted Average Basic Shares Outstanding	15.43M	15.37M	17.63M	18.54M	19.07M	18.66M	20.57M	25.44M	38.21M	44.01M
Adjusted Diluted Earnings per Share	$0.18	$0.20	$0.11	$0.29	$0.34	$0.22	$0.17	$0.32	($1.10)	($0.61)
Adjusted Weighted Average Diluted Shares Outstanding	19.66M	32.56M	94.74M	35.53M	35.76M	35.31M	96.24M	96.64M	38.21M	44.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	76.35M	77.88M	78.39M	79.00M	79.32M	80.53M	80.59M	81.91M	88.13M	102.31M
Normalized Net Operating Profit after Tax (NOPAT)	25	24	21	29	28	27	22	32	20	11
Normalized NOPAT Margin	24.38%	25.78%	21.60%	29.92%	29.00%	27.15%	20.95%	29.06%	19.01%	10.83%
Pre Tax Income Margin	21.57%	24.50%	9.94%	34.18%	40.25%	34.96%	15.61%	31.18%	-79.19%	-45.83%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-537.57	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	137.60	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-550.98	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	124.19	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	196.05%	27.53%	39.78%	45.12%	37.66%	34.09%	32.64%	37.12%	-1,570.32%	-71.38%
Augmented Payout Ratio	196.05%	27.53%	39.78%	45.12%	37.66%	34.09%	32.64%	37.12%	-1,570.32%	-71.38%

Frequently Asked Questions About CompoSecure's Financials

When does CompoSecure's fiscal year end?

According to the most recent income statement we have on file, CompoSecure's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CompoSecure's net income changed over the last 5 years?

CompoSecure's net income appears to be on a downward trend, with a most recent value of -$83.16 million in 2024, falling from $81.47 million in 2019. The previous period was $112.52 million in 2023. See CompoSecure's forecast for analyst expectations on what’s next for the company.

What is CompoSecure's operating income?

CompoSecure's total operating income in 2024 was $107.62 million, based on the following breakdown:

Total Gross Profit: $219.23 million
Total Operating Expenses: $111.61 million

How has CompoSecure revenue changed over the last 5 years?

Over the last 5 years, CompoSecure's total revenue changed from $243.29 million in 2019 to $420.57 million in 2024, a change of 72.9%.

How much debt does CompoSecure have?

CompoSecure's total liabilities were at $617.36 million at the end of 2024, a 51.8% increase from 2023, and a 125.4% increase since 2020.

How much cash does CompoSecure have?

In the past 4 years, CompoSecure's cash and equivalents has ranged from $13.42 million in 2020 to $77.46 million in 2024, and is currently $77.46 million as of their latest financial filing in 2024.

How has CompoSecure's book value per share changed over the last 5 years?

Over the last 5 years, CompoSecure's book value per share changed from 0.00 in 2019 to -1.63 in 2024, a change of -162.8%.

Related Companies

This page (NASDAQ:CMPO) was last updated on 5/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CompoSecure (CMPO) Financials

Frequently Asked Questions About CompoSecure's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CompoSecure (CMPO) Financials

Annual Income Statements for CompoSecure

Quarterly Income Statements for CompoSecure

Annual Cash Flow Statements for CompoSecure

Quarterly Cash Flow Statements for CompoSecure

Annual Balance Sheets for CompoSecure

Quarterly Balance Sheets for CompoSecure

Annual Metrics and Ratios for CompoSecure

Quarterly Metrics and Ratios for CompoSecure

Frequently Asked Questions About CompoSecure's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools